Though globally prevalent, infections rarely progress to bacteremia (shigellemia), particularly in immunocompetent individuals. Here, we report a case of shigellemia with extended-spectrum beta-lactamase (ESBL) in Qatar, involving a 53-year-old immunocompetent male with no significant medical history. The patient presented with a one-day history of frequent loose stools, fever, and mild central abdominal pain. Stool and blood cultures confirmed infection and shigellemia with ESBL production. The patient tested negative for human immunodeficiency virus (HIV), had normal immunoglobulin levels, and was successfully treated with a 10-day course of ertapenem, achieving full recovery. This case underscores the importance of considering shigellemia in patients with severe gastrointestinal symptoms, even without immunosuppression. It highlights the need for prompt diagnosis, antibiotic susceptibility testing, and targeted antimicrobial therapy, especially given the rising prevalence of antibiotic-resistant strains. A thorough investigation of predisposing factors and patient education on hygiene practices remains essential to prevent transmission and mitigate community outbreaks.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11888788PMC
http://dx.doi.org/10.7759/cureus.78566DOI Listing

Publication Analysis

Top Keywords

extended-spectrum beta-lactamase
8
diarrhea bacteremia
4
bacteremia extended-spectrum
4
beta-lactamase esbl-producing
4
esbl-producing shigella
4
shigella rare
4
rare clinical
4
clinical scenario
4
scenario globally
4
globally prevalent
4

Similar Publications

Introduction: Antimicrobial resistance (AMR) is one of the major global concerns in the current scenario. Mass-gathering events in fast-developing and densely populated areas may contribute to antibiotic resistance. Despite meticulous planning and infrastructure development, the effect of mass gatherings on microbial ecosystems and antibiotic resistance must be investigated.

View Article and Find Full Text PDF

Whole-genome sequencing-based species classification, multilocus sequence typing, and antibiotic resistance mechanisms of the clinical complex.

Front Microbiol

February 2025

Key Laboratory of Medical Genetics of Zhejiang Province, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.

Background: Multidrug-resistant strains of the genus can produce various β-lactamases that confer resistance to a broad spectrum of β-lactams, which poses a significant public health threat due to their emergence and spread in clinical settings and natural environments. Therefore, a comprehensive investigation into the antibiotic resistance mechanisms of is scientifically significant.

Methods: Between 2018 and 2021, 78 clinical isolates were collected from human clinical specimens.

View Article and Find Full Text PDF

Antibiotic resistance of urinary pathogens after kidney transplantation: a 10-year single-center survey in Germany.

Infection

March 2025

Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Purpose: Urinary tract infections (UTIs) are common complications after kidney transplantation (KT), often resulting in severe outcomes like acute graft failure and sepsis. Factors such as diabetes, age, sex, and type of transplantation significantly influence disease progression. Rising antibiotic resistance complicates treatment, emphasizing the importance of Antimicrobial Stewardship (AMS), particularly during the post-transplant immunosuppression phase.

View Article and Find Full Text PDF

The complex (ECC) comprises multiple species that require genomic analysis for precise identification. They produce inducible AmpC β-lactamase and may carry acquired β-lactamases, which are responsible for cefotaxime and cefepime resistance. To determine the molecular epidemiology, antimicrobial resistance, and β-lactam resistance mechanisms of the ECC, we conducted whole-genome sequencing analysis, antimicrobial susceptibility testing, and mutation analysis on bloodstream ECC isolates from patients in Kyoto, Japan.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!